Venetoclax and ibrutinib therapy shows favourable results in the treatment of R/R chronic lymphocytic leukaemia

Chest wall perforator flaps in breast cancer surgery: An overview

Radiation therapy after radical surgery in prostate cancer

Pembrolizumab benefits patients with brain metastases

Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma

A randomised trial of the FLT3 inhibitor gilteritinib as post-transplant maintenance for FLT3-ITD AML

Single infusion of cilta-cel sees longer median PFS than any previously reported therapy in heavily pretreated RRMM

Atezolizumab, obinutuzumab and venetoclax combination is active and leads to durable remissions in previously untreated DLBCL-RS

Addition of blinatumomab to mini-hyper-CVD and inotuzumab improves outcomes in R/R ALL

Ponatinib superior to imatinib in combination with reduced-intensity chemotherapy in newly diagnosed Ph positive ALL

Efficacy and safety of belantamab mafodotin vs pomalidomide plus dexamethasone in relapsed/refractory multiple myeloma

Belamaf monotherapy induced rapid responses without unexpected toxicity in relapsed or refractory light chain amyloidosis